Hepatitis B Vaccination Socialization Webinar at the Student Forum of Seribu Islands District, North Jakarta, Indonesia
DOI:
https://doi.org/10.70410/japm.v1i1.17Keywords:
Hepatitis B; Disease; Hepatitis B Virus (HBV)Abstract
Viral hepatitis is an infectious disease that is a public health problem in developing countries around the world, including Indonesia. Viral hepatitis can affect the morbidity rate. Hepatitis B is caused by the Hepatitis B virus (HBV). Hepatitis B can be prevented with a safe and effective vaccine that is currently available. The purpose of this community service activity is to provide knowledge to the Thousand Islands Student Forum regarding the definition of Hepatitis B disease, the types of Hepatitis B disease and its causes. In addition, we conducted a socialization activity regarding hepatitis vaccination as a form of prevention effort against Hepatitis B disease. The method used by community service members is the presentation method with the help of powerpoint slides through the google meet application. This activity involved the participation of students from the Morning Pharmaceutical Biotechnology class B, Even Academic Year 2020/2021 and the Thousand Islands Student Forum. The results achieved were increasing knowledge to the Thousand Islands Student Forum about Hepatitis B disease and the Hepatitis B vaccine as seen from the results of throwing questions to the committee. The benefits obtained from this activity such as providing more knowledge and educating the Thousand Islands Student Forum about various types of Hepatitis B vaccines for routine immunization programs as a preventive measure against Hepatitis B disease.
References
Centers for Disease Control and Prevention. (2006). A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. MMWR. 55 (No. RR-16):5, 10.
Kementerian Kesehatan RI. (2013). Riset Kesehatan Dasar. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. hlm 71.
Kementerian Kesehatan RI. (2013). Peraturan menteri kesehatan Republik Indonesia nomor 42 tahun 2013 tentang penyelenggaraan imunisasi. Jakarta: Kementerian Kesehatan RI. hlm 18.
Salama II, Sami SM, Said ZN, et al. (2015). Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project. World J Hepatol. Vol.7(22):2418-2426
Kementerian Kesehatan RI (2015). Peraturan Menteri Kesehatan Nomor 53 Tahun 2015 tentang Penanggulangan Hepatitis Virus. Diakses 24 April 2021
Koalisi Aksi Imunisasi. (2018). Pernyataan Informasi Vaksin - Hepatitis B [Terjemahan Bahasa Indonesia]. Diakses dari www.immunize.org/vis Diakses 24 April 2021
World Health Organization (2020). Hepatitis B. dari https://www.who.int/news-room/fact- sheets/detail/hepatitis-b Diakses pada 24 April 2021
World Health Organization. Global Progress. Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, (2021) Accountability for the Global Health Sector Strategies 2016–2021: Actions for Impact; World Health Organization: Geneva, Switzerland, 2021. Available online: https://apps.who.int/iris/handle/10665/342813
Mercan Ba¸spınar, M.(2022) Screening of hepatitis A and B seropositivity among Turkish healthcare providers admitted to occupational health services. Int. J. Clin. Pract, 6065335.
Ijoma, U.N.; Meka, I.A.; Omotowo, B.; Nwagha, T.U.; Obienu, O.; Onodugo, O.D.; Onyekonwu, C.L.; Okoli, E.V.; Ndu, A.C.; Ugwu, E.O.(2021) Sero-prevalence of Hepatitis B virus infection: A cross-sectional study of a large population of health care workers in Nigeria. Niger. J. Clin. Pract, 24, 38–44.
Hiva, S., Negar, K., Mohammad-Reza, P., Gholam-Reza, G., Mohsen, A., Ali-Asghar, N. G., & Mohammed-Jafar, S. (2020). High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: A cross-sectional study. BMC Public Health, 20, 920.
Shao, E. R., Mboya, I. B., Gunda, D. W., Ruhangisa, F. G., Temu, E. M., Nkwama, M. L., Pyuza, J. J., Kilonzo, K. G., Lyamuya, F. S., & Maro, V. P. (2018). Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infectious Diseases, 18, 474.
Yizengaw, E., Getahun, T., Geta, M., Mulu, W., Ashagrie, M., Hailu, D., & Tedila, S. (2018). Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of North-west Ethiopia. BMC Research Notes, 11, 437.
Massaquoi, T.A.; Burke, R.M.; Yang, G.; Lakoh, S.; Sevalie, S.; Li, B.; Jia, H.; Huang, L.; Deen, G.F.; Beynon, F.; et al. (2018) Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone. PLoS ONE, 13, e0201820.
Akazong, E.; Tume, C.; Njouom, R.; Ayong, L.; Fondoh, V.; Kuiate, J.R.(2020) Knowledge, attitude and prevalence of hepatitis B virus among healthcare workers: A cross-sectional, hospital-based study in Bamenda Health District, NWR, Cameroon. BMJ Open, 10, e031075.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Jurnal Adiguna Pengabdian Masyarakat
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in Jurnal Adiguna Pengabdian Masyarakat agree to the following terms:
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. CC BY includes the following elements:
BY: credit must be given to the creator.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.